Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis

Purpose: Chimeric Antigen Receptor T(CAR-T) cell therapy is an immunotherapy approach used in treating cancer which has seen rapid development over the decades. It becomes the preferred treatment choice after patients have failed conventional chemotherapy. Methods: We conducted a meta-analysis in 32...

Descripción completa

Detalles Bibliográficos
Autores principales: Drokow, Emmanuel Kwateng, Ahmed, Hafiz Abdul Waqas, Amponsem-Boateng, Cecilia, Akpabla, Gloria Selorm, Song, Juanjuan, Shi, Mingyue, Sun, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511615/
https://www.ncbi.nlm.nih.gov/pubmed/31190844
http://dx.doi.org/10.2147/TCRM.S203822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511615/
https://www.ncbi.nlm.nih.gov/pubmed/31190844
http://dx.doi.org/10.2147/TCRM.S203822

Ejemplares similares